PD
NVCR icon

Point72 (DIFC)’s NovoCure NVCR Stock Holding History

Point72 (DIFC)’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$68.2K Buy
5,280
+2,585
+96% +$34.5K ﹤0.01% 670
2025
Q2 		$48K Buy
+2,695
New +$47K ﹤0.01% 1072
2024
Q2 		– Sell
-37,036
Closed -$579K – 1776
2024
Q1 		$579K Buy
+37,036
New +$545K 0.02% 707

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Point72 (DIFC)'s NVCR Position: Q3 2025 in Review

Point72 (DIFC) increased its NovoCure (NVCR) stake by 96% in Q3 2025, buying an estimated $34.5K and bringing the position to 5,280 shares worth $68.2K. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Point72 (DIFC) first reported a position in NVCR in Q1 2024 and has held it in 3 quarters since. The position peaked at $579K in Q1 2024. 244 funds tracked by Wall St. Rank hold NVCR as of Q3 2025.

  • Point72 (DIFC) held 5,280 shares of NovoCure worth $68.2K as of Q3 2025.
  • Point72 (DIFC) bought 2,585 NovoCure shares in Q3 2025, an estimated $34.5K.
  • NovoCure made up ﹤0.01% of Point72 (DIFC)'s portfolio in Q3 2025, its #670 holding.
  • Point72 (DIFC) first reported a position in NovoCure in Q1 2024 and has held it in 3 quarters since.
  • Point72 (DIFC)'s NovoCure position peaked at $579K in Q1 2024.
  • 244 funds tracked by Wall St. Rank held NovoCure as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.